التفاصيل البيبلوغرافية
| العنوان: |
Outcome of immunosuppression in children with IgA vasculitis–related nephritis |
| المؤلفون: |
Rohner, Katharina, Marlais, Matko, Ahn, Yo Han, Ali, Alaa, Alsharief, Abrar, Novak, Anja Blejc, Brambilla, Marta, Cakici, Evrim Kargin, Candan, Cengiz, Canpolat, Nur, Chan, Eugene Yu-hin, Decramer, Stéphane, Didsbury, Madeleine, Durao, Filipa, Durkan, Anne M, Düzova, Ali, Forbes, Thomas, Gracchi, Valentina, Güngör, Tulin, Horinouchi, Tomoko, Kasap Demir, Belde, Kobayashi, Yasuko, Koskela, Mikael, Kurt-Sukur, Eda Didem, La Scola, Claudio, Langan, Dean, Li, Xiaozhong, Malgieri, Gabriele, Mastrangelo, Antonio, Min, Jeesu, Mizerska-Wasiak, Malgorzata, Moussaoui, Nabila, Noyan, Aytul, Nuutinen, Matti, O'Gormon, Jennifer, Okamoto, Takayuki, Oni, Louise, Oosterveld, Michiel, Pańczyk-Tomaszewska, Malgorzata, Parmaksiz, Gonul, Pasini, Andrea, Rianthavorn, Pornpimol, Roelofs, Joris, Shen, Yunyan, Sinha, Rajiv, Topaloglu, Rezan, Torres, Diletta Domenica, Udagawa, Tomohiro, Wennerström, Martin, Yap, Yok Chin |
| المصدر: |
Nephrology Dialysis Transplantation ; ISSN 0931-0509 1460-2385 |
| بيانات النشر: |
Oxford University Press (OUP) |
| سنة النشر: |
2024 |
| الوصف: |
Background Immunoglobulin A vasculitis with nephritis (IgAVN) is the most common vasculitis in children. Due to a lack of evidence, treatment recommendations are based on expert opinion, resulting in variation. The aim of this study was to describe the clinical presentation, treatment and outcome of an extremely large cohort of children with biopsy-proven IgAVN in order to identify prognostic risk factors and signals of treatment efficacy. Methods Retrospective data were collected on 1148 children with biopsy-proven IgAVN between 2005 and 2019 from 41 international paediatric nephrology centres across 25 countries and analysed using multivariate analysis. The primary outcome was estimated glomerular filtration rate (eGFR) and persistent proteinuria at last follow-up. Results The median follow-up was 3.7 years (interquartile range 2–6.2). At last follow-up, 29% of patients had an eGFR <90 mL/min/1.73 m2, 36% had proteinuria and 3% had chronic kidney disease stage 4–5. Older age, lower eGFR at onset, hypertension and histological features of tubular atrophy and segmental sclerosis were predictors of poor outcome. There was no evidence to support any specific second-line immunosuppressive regimen being superior to others, even when further analysing subgroups of children with reduced kidney function, nephrotic syndrome or hypoalbuminemia at onset. Delayed start of immunosuppressive treatment was associated with a lower eGFR at last follow-up. Conclusion In this large retrospective cohort, key features associated with disease outcome are highlighted. Importantly, there was no evidence to support that any specific immunosuppressive treatments were superior to others. Further discovery science and well-conducted clinical trials are needed to define accurate treatment and improve outcomes of IgAVN. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1093/ndt/gfae009 |
| DOI: |
10.1093/ndt/gfae009/56546252/gfae009.pdf |
| الإتاحة: |
https://doi.org/10.1093/ndt/gfae009Test |
| حقوق: |
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_modelTest |
| رقم الانضمام: |
edsbas.30B44910 |
| قاعدة البيانات: |
BASE |
